Sommaire
Littérature scientifique sur le sujet « Drug Induced Gingival Overgrowth, Laser »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Drug Induced Gingival Overgrowth, Laser ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Drug Induced Gingival Overgrowth, Laser"
Закиров, Т., T. Zakirov, Е. Бимбас, E. Bimbas, Т. Стати et T. Stati. « VARIOUS MANIFESTATIONS OF HYPERPLASIA OF PERIODONTAL TISSUES IN CHILDREN ». Actual problems in dentistry 9, no 3 (25 juin 2013) : 56–62. http://dx.doi.org/10.18481/2077-7566-2013-0-3-56-62.
Texte intégralMuralikrishna, Tupili, Butchibabu Kalakonda, Sumanth Gunupati et Pradeep Koppolu. « Laser-Assisted Periodontal Management of Drug-Induced Gingival Overgrowth under General Anesthesia : A Viable Option ». Case Reports in Dentistry 2013 (2013) : 1–4. http://dx.doi.org/10.1155/2013/387453.
Texte intégralFornaini, Carlo, et Jean Paul Rocca. « CO2 LASER TREATMENT OF DRUG-INDUCED GINGIVAL OVERGROWTH ». LASER THERAPY 21, no 1 (2012) : 39–42. http://dx.doi.org/10.5978/islsm.12-cr-01.
Texte intégralHegde, Rashmi, Rahul Kale et A. Sanjay Jain. « Cyclosporine and Amlodipine Induced Severe Gingival Overgrowth - Etiopathogenesis and Management of a Case with Electrocautery and Carbon-Dioxide(CO2) Laser ». Journal of Oral Health and Community Dentistry 6, no 1 (janvier 2012) : 34–42. http://dx.doi.org/10.5005/johcd-6-1-34.
Texte intégralMATTSON, JOHN S., RICHARD BLANKENAU et JOSEPH J. KEENE. « USE OF AN ARGON LASER TO TREAT DRUG-INDUCED GINGIVAL OVERGROWTH ». Journal of the American Dental Association 129, no 1 (janvier 1998) : 78–83. http://dx.doi.org/10.14219/jada.archive.1998.0024.
Texte intégralCampos, Luana, Marina Gallottini, Débora Pallos, Alyne Simões et Fabiana Martins. « High-power diode laser on management of drug-induced gingival overgrowth : Report of two cases and long-term follow-up ». Journal of Cosmetic and Laser Therapy 20, no 4 (19 janvier 2018) : 215–19. http://dx.doi.org/10.1080/14764172.2017.1400165.
Texte intégralNakib, Nuha, et Seema S. Ashrafi. « Drug-Induced Gingival Overgrowth ». Disease-a-Month 57, no 4 (avril 2011) : 225–30. http://dx.doi.org/10.1016/j.disamonth.2011.03.010.
Texte intégralDongari, Anna, Howard T. McDonnell et Robert P. Langlais. « Drug-induced gingival overgrowth ». Oral Surgery, Oral Medicine, Oral Pathology 76, no 4 (octobre 1993) : 543–48. http://dx.doi.org/10.1016/0030-4220(93)90027-2.
Texte intégralMANAA, R., M. Ben Salem, N. Ben Mahmoud, M. Ben Salah, I. Handous, A. Letaeif, M. Hammouda, S. Aloui et H. Skhiri. « POS-503 DRUG INDUCED GINGIVAL OVERGROWTH ». Kidney International Reports 7, no 2 (février 2022) : S221. http://dx.doi.org/10.1016/j.ekir.2022.01.534.
Texte intégralAryal, Deepa, Kripa Shahi et Surendra Man Shrestha. « Amlodipine induced Gingival Overgrowth ». Journal of Nepalese Society of Periodontology and Oral Implantology 2, no 1 (4 juin 2018) : 30–32. http://dx.doi.org/10.3126/jnspoi.v2i1.23608.
Texte intégralThèses sur le sujet "Drug Induced Gingival Overgrowth, Laser"
ORDESI, PAOLO ROBERTO MARIA. « Terapia laser-assistita dell'ipertrofia gengivale farmaco indotta:correlazioni cliniche ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2013. http://hdl.handle.net/10281/43370.
Texte intégralThomason, J. Mark. « Drug-induced gingival overgrowth in organ transplant patients ». Thesis, University of Newcastle Upon Tyne, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.261599.
Texte intégralMorgan, Clare Louise. « The role of TGF β in drug-induced gingival overgrowth ». Thesis, University of Newcastle Upon Tyne, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.341770.
Texte intégralMavrogiannis, Michail. « Investigations into the management and pathogenesis of drug-induced gingival overgrowth in organ transplant patients ». Thesis, University of Newcastle Upon Tyne, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.413947.
Texte intégralSerra, Ryan J. Nares Salvador. « Phenytoin and its metabolite, 5-p-Hydroxyphenyl-, 5-Phenylhydantoin, decrease supernatant levels of matrix-metalloproteases in the human macrophage implications for drug-induced gingival overgrowth / ». Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2009. http://dc.lib.unc.edu/u?/etd,2427.
Texte intégralTitle from electronic title page (viewed Sep. 3, 2009). "... in partial fulfillment of the requirements for the degree of Master of Science in the School of Dentistry Periodontology." Discipline: Periodontology; Department/School: Dentistry.
Rezende, Nathalie Pepe Medeiros de. « Identificação do vírus Epstein-Barr (EBV) e do papiloma vírus humano (HPV) através da técnica de hibridização in situ em hiperplasias gengivais medicamentosas de pacientes transplantados renais ». Universidade de São Paulo, 2007. http://www.teses.usp.br/teses/disponiveis/23/23141/tde-07052007-154315/.
Texte intégralIn order to prevent graft rejection in organ transplantation, is necessary the use of immunosuppressive drugs, as cyclosporin, that has several side effects, such as high blood pressure, nephrotoxicity, hepatotoxicity and gingival overgrowth (GO), that can be increased if calcium channel blockers, such as nifedipine, are associated in order to control de blood pressure. The pathogenesis of GO is still uncertain, but some factors such as the presence of calculus and plaque, drug plasmatic concentration, age and hormonal factors can influence the clinical aspects and development of GO. Recently some virus have been associated to GO as well. HPV (Human Papilloma Virus) have been associated to severe cases of GO and EBV (Epstein-Barr Virus) have been associated to posttransplantation lymphoproliferative disorders presenting as GO. The aim of this work was to evaluate GO incidence and score in renal transplant patients (RTP), identify EBV and HPV in GO from RTP, and correlate GO, plaque score, presence of calculus, and presence of EBV and HPV in RTP. We reviewed 58 charts from RTP attending to Special Care Dentistry Center (CAPE-FOUSP). Immunosuppressant drugs and presence or absence of GO were registered. 15 RTP were asked to show up in order to be examined. We collected demographic data, medical history, drugs in use and dental history. In intra-oral exam we observed plaque score, GO score and presence of calculus. GO were removed and sent to Oral Pathology Department for microscopic analysis. GO was compared to a control group composed by 20 cases of inflammatory gingival hyperplasia and both groups were submitted to routine exam emphasizing the presence of koilocytes and to molecular analysis with in situ hybridization for EBV (EBER and Lytic probes) and for HPV (wide spectrum probe and 6/11, 16/18, 31/33 types in cases where wide spectrum were positive). 42% of the patients presented GO score 1, 50% score 2 and 8% score 3. Calculus were presented in 50% of the patients. The average of plaque score was 72%.All GO specimens removed had a histopathological exam compatible with drug induced gingival overgrowth. Koilocytes were presented in 100% of study group (SG) and in 80% of control group (CG). HPV were presented in 20% of the SG and in 10% of the CG. EBV was presented in 100% of SG and in 90% of CG, for both probes, but in SG it could be observed in deeper areas of the epithelium and in a more pronounced expression. We concluded that most RTP presented mild to moderate GO, EBV were found in all RTP, characterizing an opportunistic infection, while HPV were found in the same proportions than in the control group and there were no statistical correlation between GO, plaque score, presence of calculus and presence of EBV and HPV.
Walsh, Priscilla M. « Epithelial cell integrin phenotype in drug-induced gingival overgrowth tissue ». Thesis, 2000. http://hdl.handle.net/2429/11009.
Texte intégralWan-Teng, Huang, et 黃萬騰. « Immunohistochemical analysis of cytokine profile and androgen receptor of drug induced gingival overgrowth ». Thesis, 2001. http://ndltd.ncl.edu.tw/handle/03515427984046024392.
Texte intégral台北醫學院
口腔復健醫學研究所
89
Abstract The purpose of this study is try to compare the androgen receptor+ cell (AR) (﹪),Th1/Th2 cytokine profile(﹪):IL-2, IFN-γ, IL-4,IL-10,IL-13 in the patients with healthy periodontium(PD<3mm, age range30-47),inflammatory tissues of patients with adult periodontitis(P) with PD>5mm,(n=15,age range28-55),surgically extracted tooth group(S) with PD>9mm,(n=10,age range24-79)and nifedipine induced ginigval overgrowth(NIGO)with probing depth(PD)>5mm,(n=5,age range51-63).After full ethical approval of patients was achieved , the clinical periodontal parameters - pocket depth(PD), bleeding on probing(BOP), and plaque control record were measured around the selected diseasd periodontal area. Gingival samples were harvested during periodontal surgery and fixed in buffered formalin. Gingival biopsies were further processed for immunohistochemical stain with primary antibody of AR,IL-2,IL-4,IFN-γ,IL-10,IL-13 antibody(Santa Cruz biotechnology, Inc. C.A. U.S.A.)by using LSAB® method(Dako) subsequently . The expression of AR,IL-2,IL-4,IFN-γ,IL-10,IL-13 positive cells was counted using grid scan by semiquantitative method. The Kruskall—Wallis test , Mann-Whitney U-test were employed for the statistical analysis. The results revealed that AR, IL-2 ,IL-4,IFN-γ,IL-10,IL-13 was intensively expressed in the nuclei of basal epithelial cells, spinosal cells ,endothelial cell ,inflammatory cells ,and gingival fibroblasts .Strong expression of AR,IFN-γ,IL-2,IL-4 were also found in the NIGO group. Percentage (﹪)of AR labeled cells were significantly higher in the NIGO group of epithelial cells and gingival fibriblasts(58.6+2.3;80.2+10.7) than in the periodontitis group (56.3+3.3;52.5+11.8)and control(38.5+4.6;37.4+11.3)(P<0.05).In the surgically extracted tooth group ,very strong expression of Th2 (IL-4,Il-10,IL-13)type cytokine were found in the inflammatory cell than the Th1(IL-2,IFN-γ) type cytokine .The immuno expression of NIGO group has trend toward to the Th1 type cytokine(IL-2:p<0.01)expression .In the periodontitis group after periodontal phase I therapy was found strongly expression of IFN-γin the inflammatory cell. It seems that as at the quiesence stage of periodontitis , periodontium has the tendency to develope to the direction of tissue repair . Based on these findings , we postulated that AR and cytokine profile might play an important role in the progression of periodontitis and overgrowth of gingiva in NIGO. Key words: gingival overgrowth, androgen receptor, periodontitis, immunohistochemistry, cytokine profile。
Chapitres de livres sur le sujet "Drug Induced Gingival Overgrowth, Laser"
Bontemps, Léa, Frédérick Gaultier, Fani Anagnostou, Anne-laure Ejeil et Sophie-Myriam Dridi. « Drug-Induced Gingival Overgrowth ». Dans Drug-Induced Oral Complications, 7–24. Cham : Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-66973-7_2.
Texte intégral« Drug-Induced Gingival Overgrowth ». Dans Treatment of Oral Diseases, sous la direction de George Laskaris. Stuttgart : Georg Thieme Verlag, 2005. http://dx.doi.org/10.1055/b-0034-55804.
Texte intégral